Design of a Phase 3 Maintenance-of-Effect Trial of Ecopipam in Tourette Syndrome

Atkinson Sarah

Emalex Biosciences
Donald L. Gilbert, MD, MS
Supported by:
Association Française du Syndrome de Gilles de LaTourette
Supporting video available
Listen to the audio presentation
View supporting document(s) shared by the author
Contact author
Trophy icon
go back